what does retatrutide target UK 2026: Phase 3 Results RETATRUTIDE: A Medication for Diabetes

For eligible adults with clinically significant obesity, MHRA-approved options include semaglutide (Wegovy, assessed in NICE TA875) and tirzepatide (Mounjaro, assessed in NICE TA1026), both available through NHS pathways with appropriate clinical oversight

1, Table 2 and Supplementary Section 5) seems more likely, while any effect on psychotic, mood and anxiety disorders appears less consistent and in need of further investigation

Key takeaways TRICARE typically covers Ozempic for Type 2 diabetesbut not for weight loss, which is an off-label use

Fermented Foods: Foods like yogurt, kefir, or sauerkraut introduce beneficial probiotics

These factors should inform shared decision-making between patient and provider, not necessarily contraindicate GLP-1, but justify closer monitoring during dose escalation

Signs of dehydration to watch: dark urine, dizziness when standing, dry mouth, reduced urine output